Global Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Low-Cost Multivalent Pneumococcal Vaccine

Kevin Killeen of Matrivax R&D Inc. in the U.S. proposes applying a novel technology which entraps many polysaccharide antigens in a protein matrix. If successful, this prototype platform could increase the breadth of serotypes currently covered by pneumococcal vaccines as well as reduce costs of vaccine production.

More information about Create New Vaccines for Diarrhea, HIV, Malaria, Pneumonia, and Tuberculosis (Round 3)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.